iRobot is a consumer robot company. The company's portfolio of solutions features technologies for the connected home and concepts in cleaning, mapping and navigation, human-robot interaction, and physical solutions. The company sells various products that are designed for use in and around the home. The company's consumer products are focused on both indoor and outdoor cleaning applications. The company provides multiple Roomba floor vacuuming robots. Roomba's design allows it to clean under toe kicks, beds and other furniture. The company provides the Braava family of automatic floor mopping robots designed for hard surface floors. The Braava automatically dusts and damp mops hard surface floors using cleaning cloths.
  • TickerIRBT
  • ISINUS4627261005
  • ExchangeNASDAQ Stock Market
  • SectorHousehold Goods & Home Construction
  • CountryUnited States
Valens Research

Valens Equity Insights and Inflections - 2020 07 28

GPS currently trades below recent averages relative to Uniform assets, with a 0.8x Uniform P/B (V/A'). At these levels, the market is pricing in expectations for Uniform ROA to slightly compress from 6% in 2020 to 5% through 2025, accompanied by 2% Uniform asset shrinkage going forward. Analysts have similarly bearish expectations, projecting Uniform ROA to fall to 2% levels through 2022, accompanied by 14% Uniform asset shrinkage. That said, management is confident about growth, margins, and e-commerce. Current valuations appear to be pricing in overly bearish expectations for GPS, and if the...

Valens Research

IRBT - Embedded Expectations Analysis - 2020 07 27

iRobot Corporation (IRBT:USA) currently trades above recent averages relative to UAFRS-based (Uniform) earnings with a 26.9x Uniform P/E. Even at these levels, the market has bearish expectations for the firm, and management may be concerned about sell-through growth, costs, and retailer headwinds Specifically, management may lack confidence in the potential of cost-reduction actions undertaken to reprioritize resources. Management may also lack confidence in their ability to sustain their sell-through growth in the U.S. and EMEA and support manufacturing in Malaysia, and might have concerns ...

IROBOT suffers a double requalification, which weighs heavily on its rating, now at Slightly Negative.

The independent financial analyst theScreener just downgraded the general evaluation of IROBOT (US), active in the Electronic Equipment industry. As regards its fundamental valuation, the title loses a star(s) and now shows 1 out of 4 stars. Its market behaviour is also negatively reassessed and may be considered as risky. theScreener believes that this double requalification keeps the title under pressure and justifies an overall rating downgrade to Slightly Negative. As of the analysis date July 24, 2020, the closing price was USD 71.55 and its target price was estimated at USD 57.08.

Irobot Corp: 1 director sold

A director at Irobot Corp sold 34,099 shares at 86.433USD and the significance rating of the trade was 69/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly showing Close periods where trading activity is restricted under listing rules. The names of board me...

Dave Nicoski ...
  • Ross LaDuke

Vital Signs: Actionable charts

In this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-term patterns that may have long-term significance, etc. We believe you will find this product valuable as significant price and relative moves begin in the daily charts.

Dave Nicoski ...
  • Ross LaDuke

Vital Signs: Actionable charts

In this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-term patterns that may have long-term significance, etc. We believe you will find this product valuable as significant price and relative moves begin in the daily charts.

Dave Nicoski ...
  • Ross LaDuke

Vermilion Booster Shots: Attractive bottom-fishing stocks

For investors looking for bottom-fishing candidates; stocks that are breaking downtrends, exhibiting ascending reaction lows, and showing stabilizing relative strength.

Dave Nicoski ...
  • Ross LaDuke

Vermilion Compass: Weekly Equity Strategy

Market In “Wait-And-See” Phase We started to see waning upside momentum in the S&P 500 last week with the rising wedge breakdown and 2760 support level violation on Tuesday. Despite this, there was no downside follow through the following day as investors digested a new $484B fiscal relief package. This led to the S&P 500 finding support at 2725-2735 which leads us to where we are now -- testing recent highs. We see waning upside momentum and several aspects continue to suggest the S&P 500 remains vulnerable to a pullback, but the market is simply not breaking down. We believe some near-term ...

Dave Nicoski ...
  • Ross LaDuke

Vermilion Booster Shots: Attractive bottom-fishing stocks

For investors looking for bottom-fishing candidates; stocks that are breaking downtrends, exhibiting ascending reaction lows, and showing stabilizing relative strength.

Dave Nicoski ...
  • Ross LaDuke

Vermilion Booster Shots: Attractive bottom-fishing stocks

For investors looking for bottom-fishing candidates; stocks that are breaking downtrends, exhibiting ascending reaction lows, and showing stabilizing relative strength.

Irobot Corp: 1 director sold

A director at Irobot Corp sold 34,099 shares at 86.433USD and the significance rating of the trade was 69/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly showing Close periods where trading activity is restricted under listing rules. The names of board me...

Valens Research

Valens Equity Insights and Inflections - 2020 07 28

GPS currently trades below recent averages relative to Uniform assets, with a 0.8x Uniform P/B (V/A'). At these levels, the market is pricing in expectations for Uniform ROA to slightly compress from 6% in 2020 to 5% through 2025, accompanied by 2% Uniform asset shrinkage going forward. Analysts have similarly bearish expectations, projecting Uniform ROA to fall to 2% levels through 2022, accompanied by 14% Uniform asset shrinkage. That said, management is confident about growth, margins, and e-commerce. Current valuations appear to be pricing in overly bearish expectations for GPS, and if the...

Valens Research

IRBT - Embedded Expectations Analysis - 2020 07 27

iRobot Corporation (IRBT:USA) currently trades above recent averages relative to UAFRS-based (Uniform) earnings with a 26.9x Uniform P/E. Even at these levels, the market has bearish expectations for the firm, and management may be concerned about sell-through growth, costs, and retailer headwinds Specifically, management may lack confidence in the potential of cost-reduction actions undertaken to reprioritize resources. Management may also lack confidence in their ability to sustain their sell-through growth in the U.S. and EMEA and support manufacturing in Malaysia, and might have concerns ...

Dave Nicoski ...
  • Ross LaDuke

Vital Signs: Actionable charts

In this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-term patterns that may have long-term significance, etc. We believe you will find this product valuable as significant price and relative moves begin in the daily charts.

Dave Nicoski ...
  • Ross LaDuke

Vermilion Compass: Weekly Equity Strategy

Round Trip Back To Resistance Our base case continues to be for near-term consolidation while the market determines the implications of states' reopening (i.e., the “wait-and-see” phase). Until this consolidation period resolves below support or above resistance we are maintaining a relatively neutral stance considering the wide range of outcomes. Below we highlight new developments which remain generally positive. Still, many major indexes are testing logical resistance and until we see breakouts it is hard to get too bullish. · Short-Term Levels. The S&P 500 is at the upper-end of ...

IROBOT suffers a double requalification, which weighs heavily on its rating, now at Slightly Negative.

The independent financial analyst theScreener just downgraded the general evaluation of IROBOT (US), active in the Electronic Equipment industry. As regards its fundamental valuation, the title loses a star(s) and now shows 1 out of 4 stars. Its market behaviour is also negatively reassessed and may be considered as risky. theScreener believes that this double requalification keeps the title under pressure and justifies an overall rating downgrade to Slightly Negative. As of the analysis date July 24, 2020, the closing price was USD 71.55 and its target price was estimated at USD 57.08.

ResearchPool Subscriptions

Get the most out of your insights

Get in touch